MacroGenics Escapes Investor Stock Drop Suit
An investor suit against biopharmaceutical company MacroGenics was dismissed on Wednesday by a Maryland federal judge who said the plaintiffs failed to show enough facts to support their claims of fraud...To view the full article, register now.
Already a subscriber? Click here to view full article